Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol May. 2018;14:270–84.
McCartney Ch R, Marshall JC. Polycystic ovary syndrome. N Engl J Med Oct. 2016;6:375:1398–9.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med Jun. 2010;30:8:41.
Mikhael S, Punjala-Patel A, Gavrilova-Jordan L. Hypothalamic-Pituitary-Ovarian Axis disorders impacting female fertility. Biomedicines Jan 4 2019;7:1:5.
Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update Nov. 2016;22:687–708.
Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab Feb 1. 2017;102:604–12.
Kiddy DS, Hamilton-Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) Jan. 1992;36:105–11.
Consensus on infertility. Treatment related to polycystic ovary syndrome. Hum Reprod Mar. 2008;23:462–77.
Scragg J, Hobson A, Willis L, Taylor KS, Dixon S, Jebb SA. Effect of weight loss interventions on the symptomatic burden and biomarkers of polycystic ovary syndrome: A systematic review of randomized controlled trials. Ann Intern Med Dec. 2024;177:1664–74.
Zhang L, Feng Y, Sun X, Yi S, Xiao X, Ma F. Impact of body mass index on assisted reproductive technology outcomes in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biomed Online Jun. 2024;48:103849.
Bergant G, Abdulkhalikova D, Šuštaršič A et al. Expression of markers of endometrial receptivity in obese infertile PCOS women before and after the weight loss Program-A preliminary study. Cells Dec 30 2022;12:1:164.
Kiel IA, Lionett S, Parr EB, et al. High-Intensity interval training in polycystic ovary syndrome: A Two-Center, Three-Armed randomized controlled trial. Med Sci Sports Exerc May. 2022;1:54:717–27.
Patten RK, McIlvenna LC, Levinger I, et al. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial. Hum Reprod May. 2022;3:37:1018–29.
Santos IKD, Nunes F, Queiros VS, et al. Effect of high-intensity interval training on metabolic parameters in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2021;16:e0245023.
Article PubMed PubMed Central Google Scholar
Mohammadi S, Monazzami A, Alavimilani S. Effects of eight-week high-intensity interval training on some metabolic, hormonal and cardiovascular indices in women with PCOS: a randomized controlled trail. BMC Sports Sci Med Rehabil Mar. 2023;29:15:47.
Jedel E, Labrie F, Odén A, et al. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab Jan. 2011;300:E37–45.
Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome. J Funct Morphol Kinesiol May 31 2020;5:2:35.
Patten RK, Boyle RA, Moholdt T, et al. Exercise interventions in polycystic ovary syndrome: A systematic review and Meta-Analysis. Front Physiol. 2020;11:606.
Article PubMed PubMed Central Google Scholar
Ribeiro VB, Kogure GS, Lopes IP, et al. Effects of continuous and intermittent aerobic physical training on hormonal and metabolic profile, and body composition in women with polycystic ovary syndrome: A randomized controlled trial. Clin Endocrinol (Oxf) Aug. 2020;93:173–86.
Costa EC, De Sá JCF, Stepto NK, et al. Aerobic training improves quality of life in women with polycystic ovary syndrome. Med Sci Sports Exerc Jul. 2018;50:1357–66.
Li C, Xing C, Zhang J, Zhao H, Shi W, He B. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome. J Transl Med Apr. 2021;13:19:148.
Talebi S, Shab-Bidar S, Moini A, Mohammadi H, Djafarian K. The effects of time-restricted eating alone or in combination with probiotic supplementation in comparison with a calorie-restricted diet on endocrine and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Diabetes Obes Metab Oct. 2024;26:4468–79.
Feyzioglu BS, Güven CM, Avul Z. Eight-Hour Time-Restricted feeding: A strong candidate diet protocol for First-Line therapy in polycystic ovary syndrome. Nutrients May 10 2023;15:10:2260.
Eckel-Mahan KL, Patel VR, de Mateo S, et al. Reprogramming of the circadian clock by nutritional challenge. Cell Dec. 2013;19:155:1464–78.
Salgado-Delgado R, Angeles-Castellanos M, Saderi N, Buijs RM, Escobar C. Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinol Mar. 2010;151:1019–29.
Chellappa SL, Qian J, Vujovic N, et al. Daytime eating prevents internal circadian misalignment and glucose intolerance in night work. Sci Adv Dec. 2021;3:7:eabg9910.
Skene DJ, Skornyakov E, Chowdhury NR, et al. Separation of circadian- and behavior-driven metabolite rhythms in humans provides a window on peripheral oscillators and metabolism. Proc Natl Acad Sci U S Jul. 2018;24:115:7825–30.
Kervezee L, Cermakian N, Boivin DB. Individual metabolomic signatures of circadian misalignment during simulated night shifts in humans. PLoS Biol Jun. 2019;17:e3000303.
Asher G, Sassone-Corsi P. Time for food: the intimate interplay between nutrition, metabolism, and the circadian clock. Cell Mar. 2015;26:161:84–92.
Challet E. The circadian regulation of food intake. Nat Rev Endocrinol Jul. 2019;15:393–405.
Ezpeleta M, Cienfuegos S, Lin S, et al. Time-restricted eating: watching the clock to treat obesity. Cell Metab Feb. 2024;6:36:301–14.
Sciarra F, Franceschini E, Campolo F et al. Disruption of circadian rhythms: A crucial factor in the etiology of infertility. Int J Mol Sci May 30 2020;21:11:3943.
Pan X, Taylor MJ, Cohen E, Hanna N, Mota S. Circadian clock, Time-Restricted feeding and reproduction. Int J Mol Sci Jan 28 2020;21:3:831.
Ryu KJ, Park H, Han YI, et al. Effects of time-restricted feeding on letrozole-induced mouse model of polycystic ovary syndrome. Sci Rep Feb. 2023;2:13:1943.
Regmi P, Heilbronn LK. Time-Restricted eating: benefits, mechanisms, and challenges in translation. iScience Jun. 2020;26:23:101161.
Rossetti R, Strinati V, Caputi A et al. A ketogenic diet followed by gradual carbohydrate reintroduction restores menstrual cycles in women with polycystic ovary syndrome with oligomenorrhea independent of body weight loss: results from a Single-Center, One-Arm, pilot study. Metabolites Dec 8 2024;14:12:691.
Meneghini C, Bianco C, Galanti F et al. The impact of nutritional therapy in the management of overweight/obese PCOS patient candidates for IVF. Nutrients Oct 20 2023;15:20:4444.
Tsushima Y, Nachawi N, Pantalone KM, Griebeler ML, Alwahab UA. Ketogenic diet improves fertility in patients with polycystic ovary syndrome: a brief report. Front Nutr. 2024;11:1395977.
Article PubMed PubMed Central Google Scholar
Palafox-Gómez C, Ortiz G, Madrazo I, López-Bayghen E. Adding a ketogenic dietary intervention to IVF treatment in patients with polycystic ovary syndrome improves implantation and pregnancy. Reprod Toxicol Aug. 2023;119:108420.
Magagnini MC, Condorelli RA, Cimino L et al. Does the ketogenic diet improve the quality of ovarian function in obese women? Nutrients. Oct 6 2022;14:19:4147.
Cannarella R, Rubulotta M, Leonardi A, et al. Effects of ketogenic diets on polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol May. 2025;20:23:74.
Sharifi M, Saber A, Moludi J, Salimi Y, Jahan-Mihan A. The effects of portfolio moderate-carbohydrate and ketogenic diets on anthropometric indices, metabolic status, and hormonal levels in overweight or obese women with polycystic ovary syndrome: a randomized controlled trial. Nutr J Dec. 2024;2:23:152.
Zhao B, Wu H, Yao Q, Bai W, Kang J. A ketogenic diet alleviates the apoptosis of granulosa cells by inhibiting the activation of cGAS-STING signaling pathway in PCOS mice. Cell Commun Signal Nov. 2024;27:22:568.
Camajani E, Feraco A, Verde L, et al. Ketogenic diet as a possible Non-pharmacological therapy in main endocrine diseases of the female reproductive system: A practical guide for nutritionists. Curr Obes Rep Sep. 2023;12:231–49.
Cincione IR, Graziadio C, Marino F, et al. Short-time effects of ketogenic diet or modestly hypocaloric mediterranean diet on overweight and obese women with polycystic ovary syndrome. J Endocrinol Invest Apr. 2023;46:769–77.
Gautam R, Maan P, Jyoti A, Kumar A, Malhotra N, Arora T. The role of lifestyle interventions in PCOS management: A systematic review. Nutrients Jan 16 2025;17:2:310.
Wang F, Dou P, Wei W, Liu PJ. Effects of high-protein diets on the cardiometabolic factors and reproductive hormones of women with polycystic ovary syndrome: a systematic review and meta-analysis. Nutr Diabetes Feb. 2024;29:14:6.
Sørensen LB, Søe M, Halkier KH, Stigsby B, Astrup A. Effects of increased dietary protein-to-carbohydrate ratios in women with polycystic ovary syndrome. Am J Clin Nutr Jan. 2012;95:39–48.
Drummen M, Tischmann L, Gatta-Cherifi B, Adam T, Westerterp-Plantenga M. Dietary protein and energy balance in relation to obesity and Co-morbidities. Front Endocrinol (Lausanne). 2018;9:443.
Article PubMed PubMed Central Google Scholar
Gannon MC, Nuttall FQ. Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutr Metab (Lond). Mar 23. 2006;3:16.
Leidy HJ, Clifton PM, Astrup A, et al. The role of protein in weight loss and maintenance. Am J Clin Nutr Jun. 2015;101:s1320–9.
Comments (0)